What is Cortistatin?
Cortistatin is a neuropeptide family investigated in inflammatory signaling. The selected study used a mouse arthritis model rather than people with rheumatoid arthritis.
Biological role or research focus
Inflammatory arthritis models.
These findings do not establish reduced human joint damage or a clinically effective rheumatoid-arthritis treatment.
Role reference: Therapeutic effect of cortistatin on experimental arthritis by downregulating inflammatory and Th1 responses. · 2007 ↗
Names you may encounter
CST peptide
Search terms can include brands, combinations, or historical names. They are not automatic product equivalents.
- Class / identity
- Somatostatin-related neuropeptide family
- Research focus
- Inflammatory arthritis models
- Featured evidence
- Animal study
- Source check
- October 4, 2026
Quick answers
- Is Cortistatin FDA approved?
- No. No FDA-approved drug contains Cortistatin. Source ↗
- Is Cortistatin safe?
- Cortistatin is a natural neuropeptide studied mainly in animals. Apart from brief hormone experiments, it has no human safety studies. Human safety data: none. The Risks & interactions section below lists what is known. Read the risks ↓
- Is Cortistatin banned in sport?
- Very likely. The 2026 World Anti-Doping Agency (WADA) Prohibited List does not name it, but it appears to fall under a banned class (S0 Non-approved substances). Source ↗
What does the evidence show?
Evidence map
Every study featured on this page, grouped by what was actually tested. Human studies count most; animal and cell results often do not carry over to people.
| Study | Type | Population / model |
|---|---|---|
| Cortistatin in collagen-induced arthritis (2007) | Animal study | DBA/1J mice with collagen-induced arthritis. |
Selected published evidence, with the population, findings, and limits kept together. These original summaries draw on publication abstracts; they are not a systematic review.
Animal study · 2007
Cortistatin in collagen-induced arthritis
What did this publication test, and what did it find?
- Population / model
- DBA/1J mice with collagen-induced arthritis.
- Study design
- Animal intervention with clinical, tissue, and inflammatory immune-response measurements.
- Main finding
- The report described improved arthritis measures and reduced inflammatory responses, including changes in the Th1 response.
- Limits & context
- These findings do not establish reduced human joint damage or a clinically effective rheumatoid-arthritis treatment.
Read the original paper for methods, adverse events, funding, and conflicts of interest. Publisher access may require a subscription.
Registered human trials
No study naming Cortistatin as an intervention was found on ClinicalTrials.gov when we last checked (November 16, 2026). That means no registered human trial, not proof that none has ever been done elsewhere.
Further reading · 4 additional publication links
Exact-name PubMed search checked 2026-10-04. These records have not been appraised. A name match can include related compounds, combinations, or other formulations; it does not establish safety or benefit.
Structure, function and pharmacology of human itch GPCRs. ↗
Nature · 2021 Dec · Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
Read available full text ↗
Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review). ↗
International journal of molecular medicine · 2018 Aug · Journal Article, Review
Read available full text ↗
Somatostatin receptors. ↗
Biochimica et biophysica acta · 2003 Sep 22 · Journal Article, Review
Cortistatin exerts an immunomodulatory and neuroprotective role in a preclinical model of ischemic stroke. ↗
Pharmacological research · 2024 Dec · Journal Article
Risks & interactions
Cortistatin is a natural neuropeptide studied mainly in animals. Apart from brief hormone experiments, it has no human safety studies.
Short hormone experiments gave cortistatin-14 to small groups of healthy adults and found it suppressed growth hormone and insulin release, but no human safety studies were found. Infection risk, endocrine effects and long-term safety are unknown.
Unassessed: no human safety data
It isn't approved, so there is no official list of who should avoid it, and no human safety studies have been published. No condition is tagged, but that does not make it safe for anyone. If a condition applies to you, talk to a doctor or pharmacist first.
Who should not use it
There is no official list, because it has never been approved as a medicine. That is not a sign it is safe for anyone: its risks have not been studied enough to know who is most at risk.
Summarized from published studies with AI assistance; not reviewed by a clinician. Not a complete list, and not medical advice: talk to a doctor or pharmacist about your own situation. Checked 2026-10-10. Sources: Cortistatin in experimental arthritis (2007) ↗ · Endocrine activities of cortistatin-14 in humans (2002) ↗
Safety & what remains unknown
A mouse inflammation model cannot determine human infection risk, endocrine effects, or long-term safety.
Evidence boundaries
These findings do not establish reduced human joint damage or a clinically effective rheumatoid-arthritis treatment.
Regulatory status
- U.S. FDA approval
- Not approved
No FDA-approved drug containing this substance found in Drugs@FDA (openFDA data updated 2026-10-07). source - FDA compounding (503A bulk list)
- Not on FDA’s compounding lists
Not found on FDA's 503A category 1, 2 or 3 lists (updated May 14, 2026) or the category 2 safety-risk page (updated April 22, 2026). source - World Anti-Doping Agency (2026)
- Likely prohibited under a class rule · S0 Non-approved substances
Not named. S0 prohibits (at all times) any pharmacological substance not covered by another section and with no current approval by any government health authority for human therapeutic use; no such approval was found, so it is likely covered. source
Checked October 28, 2026. Rules change; follow the source links for the current status. Regulatory tracker.
This is not a complete list of contraindications, interactions, or adverse effects. Medicine labels apply to specific products and indications; research-use listings are not interchangeable with approved medicines.
Research context & identity
This profile covers a collagen-induced arthritis model and distinguishes laboratory immunology from a validated arthritis medicine.
New editorial updates
New source discoveries
Links appear automatically. Unreviewed discoveries are not verified medical findings.
Sources & supplier listings
Listings are grouped by the vendor’s stated identity. Blends and modified derivatives are labeled separately. Inclusion is not a quality assessment or an endorsement.
We have not added a supplier for this profile. Missing products and coded listings are not filled with guesses.
Biology & proposed mechanism
The investigators examined immune responses involving somatostatin- and ghrelin-receptor pathways. Experimental pathway effects do not establish clinical disease control.
Questions worth asking
- Is this evidence from a human rheumatoid-arthritis trial?
- What material, population, and route were actually studied?
- These findings do not establish reduced human joint damage or a clinically effective rheumatoid-arthritis treatment.
- What adverse effects, uncertainty, and conflicts of interest does the original source report?
Frequently asked questions
Is this evidence from a human rheumatoid-arthritis trial?
No. The featured evidence comes from an induced mouse arthritis model.
Does the publication verify a supplier’s product?
No. The tested material and a commercial listing need separate identity and batch checks. A research-use disclaimer does not establish clinical suitability.
References & editorial record
Source notes checked 2026-10-04. Original PepsRadar summaries. Not reviewed by a medical professional. Topic grouping is editorial navigation, not a treatment recommendation.
